IRCT20210513051275N1尚未招募2 期
The Evaluation of effectiveness of heparin nebulizer in reduction of respiratory distress in patients with COVID-19
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •All patients with COVID-19 treated in Yazd In the Summer of 2021, which was proven by radiographic involvement in radiography andThey have respiratory distress and O2 SAT below 90%.
排除标准
- •Patients treated with anticoagulants
- •Patients with a variety of coagulation disorders
- •Patients who have impaired coagulation tests at initial evaluation.
- •Patients with proven cardiovascular disease
- •Patients taking medications that interfere with the medications we use.
- •Patients with severe COVID-19 who require ICU admission and mechanical ventilation prior to intervention.
- •Patients who do not have clear lung involvement on radiography and respiratory distress.
研究者
相似试验
已完成
3 期
Evaluation of the effect of nebulized heparin on days without ventilator in intensive care unit patientsAcute respiratory distress syndrom.Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vaporsJ68.3IRCT20211010052718N2Mazandaran University of Medical Sciences74
尚未招募
1 期
A trial to assess the safety of nebulised heparin for acute lung injuryAcute lung injuryRespiratory - Other injuries and accidentsACTRN12606000388516St Vincents Health Melboune20
招募中
3 期
Evaluation of nebulized heparin efficacy in acute respiratory distress syndromeIRCT20230724058907N1Ahvaz University of Medical Sciences66
已完成
不适用
Examination of usefulness and safety of heparinoid agent based external medicine (over counter drug) for facial dryness symptom.JPRN-UMIN000018986Osaka city university graduate school of medicine, department of dermatology50
已完成
2 期
Heparin administration in coronary angiographyAtherosclerotic heart disease.Atherosclerotic heart diseaseIRCT201202199080N1Hamadan university of medical sciences500